Rx Only
ceea739a-21dd-4c3a-9ef6-2b7ab2bdd95a
34391-3
HUMAN PRESCRIPTION DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Indications and Usage
Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Medication Information
Indications and Usage
Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Description
Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Package Label.principal Display Panel
NDC 14593-318-01
Tranexamic Acid Injection, USP
1000 mg/10 mL
(100 mg/mL)
Intravenous Use Only
Rx only
10 mL Single-Dose Vial
Structured Label Content
Indications and Usage (INDICATIONS AND USAGE)
Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.
Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)
NDC 14593-318-01
Tranexamic Acid Injection, USP
1000 mg/10 mL
(100 mg/mL)
Intravenous Use Only
Rx only
10 mL Single-Dose Vial
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T11:43:32.262360 · Updated: 2026-03-14T22:16:06.215005